L’Oréal Partners with Tru Diagnostic to advance beauty and longevity science

Last update on Mar 25, 2025
L'Oréal Partners with Tru Diagnostic to advance beauty and longevity science announces a strategic research and development partnership with Tru Diagnostic, the authority in epigenomics1 testing. This collaboration aims to explore the connection between beauty indicators and changes in epigenomic markers, paving the way for advancements in the field of longevity.

Develop products that promote long-term skin & hair health


With over a century of combined expertise in skin and hair biology, L'Oréal is positioned to leverage its extensive knowledge in beauty science. The partnership with Tru Diagnostic will facilitate a series of innovative studies designed to unlock the intricate relationship between epigenetics and beauty, ultimately leading to the development of advanced products that promote not just aesthetic appeal but also long-term skin and hair health, that trigger the hallmarks of longevity activation moving to long term skin and hair health management.

'Partnering with Tru Diagnostic represents a significant milestone for us,' said Guive Balooch, head of Open Innovation and Augmented Beauty at L'Oréal. 'By combining our deep understanding of beauty biology with Tru Diagnostic's cutting-edge expertise in epigenomics, we are poised to lead the field of Longevity biomarker discoveries that will bring new product offerings and valuable diagnostic insight to our consumers, to proactively care for their skin and hair health with the best longevity science solutions'.

Matthew Dawson, CEO of Tru Diagnostic, expressed his enthusiasm for the partnership, stating, 'We are excited to collaborate with L'Oréal to explore the links between epigenetic markers and beauty. Epigenomics has the potential to revolutionize how we understand beauty at a biological level. Together, we aim to lead the charge in integrating epigenetic science into the beauty industry, creating innovative products that truly reflect the future of beauty and longevity.'

This partnership underscores both companies' commitment to pioneering research and innovation, aiming to establish a leadership position in the burgeoning field of longevity within beauty. By focusing on the science of epigenetics, L'Oréal and Tru Diagnostic intend to develop groundbreaking solutions that enhance beauty from within, providing consumers with holistic approaches to skin care and hair care.

1 - Epigenomics is the study of heritable changes other than those encoded in the DNA sequence. Epigenetics includes any process that alters gene activity without change in the DNA but leads to heritable modifications.

Source: L'Oréal

Source
L’Oréal